Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice - PubMed (original) (raw)
Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice
T van der Poll et al. Am J Respir Crit Care Med. 1997 Feb.
Abstract
Streptococcus pneumoniae is the most frequent cause of community-acquired pneumonia. We sought to determine the role of tumor necrosis factor-alpha (TNF) in the pathogenesis of pneumococcal pneumonia. Induction of pneumonia in C57B1/6 mice by intranasal inoculation with 10(6) colony-forming units (cfu) S. pneumoniae resulted in a sustained increase in TNF activity in lung homogenates reaching a plateau between 12 and 72 h (72 h: 185.49 +/- 54.41 ng/g), while plasma TNF activity remained low or undetectable. Treatment with a neutralizing anti-TNF monoclonal antibody 2 h before inoculation strongly reduced lung TNF activity, but only modestly diminished lung interleukin (IL)-1beta levels, and did not significantly influence lung IL-6, IL-10, and interferon-gamma concentrations. Anti-TNF-treated mice had fourfold more S. pneumoniae cfu isolated from lungs than control mice 40 h after inoculation (p < 0.05), although lung myeloperoxidase activities were similar in both treatment groups. Anti-TNF-treated mice died significantly earlier from pneumococcal pneumonia than control mice (p < 0.05). Endogenously produced TNF is important for host defense during pneumococcal pneumonia.
Similar articles
- Interleukin-10 impairs host defense in murine pneumococcal pneumonia.
van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF. van der Poll T, et al. J Infect Dis. 1996 Nov;174(5):994-1000. doi: 10.1093/infdis/174.5.994. J Infect Dis. 1996. PMID: 8896500 - TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia.
Rijneveld AW, Florquin S, Branger J, Speelman P, Van Deventer SJ, van der Poll T. Rijneveld AW, et al. J Immunol. 2001 Nov 1;167(9):5240-6. doi: 10.4049/jimmunol.167.9.5240. J Immunol. 2001. PMID: 11673538 - Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia.
van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M, Lowry SF. van der Poll T, et al. J Infect Dis. 1997 Aug;176(2):439-44. doi: 10.1086/514062. J Infect Dis. 1997. PMID: 9237710 - Pathogenesis of pneumococcal pneumonia.
Johnston RB Jr. Johnston RB Jr. Rev Infect Dis. 1991 May-Jun;13 Suppl 6:S509-17. doi: 10.1093/clinids/13.supplement_6.s509. Rev Infect Dis. 1991. PMID: 1862280 Review. - Obesity, leptin and host defence of Streptococcus pneumoniae: the case for more human research.
Hales C, Burnet L, Coombs M, Collins AM, Ferreira DM. Hales C, et al. Eur Respir Rev. 2022 Aug 23;31(165):220055. doi: 10.1183/16000617.0055-2022. Print 2022 Sep 30. Eur Respir Rev. 2022. PMID: 36002169 Free PMC article. Review.
Cited by
- Leptin improves pulmonary bacterial clearance and survival in ob/ob mice during pneumococcal pneumonia.
Hsu A, Aronoff DM, Phipps J, Goel D, Mancuso P. Hsu A, et al. Clin Exp Immunol. 2007 Nov;150(2):332-9. doi: 10.1111/j.1365-2249.2007.03491.x. Epub 2007 Sep 5. Clin Exp Immunol. 2007. PMID: 17822444 Free PMC article. - Streptococcus pneumoniae autolysis prevents phagocytosis and production of phagocyte-activating cytokines.
Martner A, Skovbjerg S, Paton JC, Wold AE. Martner A, et al. Infect Immun. 2009 Sep;77(9):3826-37. doi: 10.1128/IAI.00290-09. Epub 2009 Jun 15. Infect Immun. 2009. PMID: 19528220 Free PMC article. - Streptococcus pneumoniae aminopeptidase N contributes to bacterial virulence and elicits a strong innate immune response through MAPK and PI3K/AKT signaling.
Wang L, Zhang X, Wu G, Qi Y, Zhang J, Yang J, Wang H, Xu W. Wang L, et al. J Microbiol. 2020 Apr;58(4):330-339. doi: 10.1007/s12275-020-9538-0. Epub 2020 Feb 27. J Microbiol. 2020. PMID: 32103444 - Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice.
Bergeron Y, Ouellet N, Deslauriers AM, Simard M, Olivier M, Bergeron MG. Bergeron Y, et al. Infect Immun. 1998 Mar;66(3):912-22. doi: 10.1128/IAI.66.3.912-922.1998. Infect Immun. 1998. PMID: 9488375 Free PMC article. - Bacterium-like Particles from Corynebacterium pseudodiphtheriticum as Mucosal Adjuvant for the Development of Pneumococcal Vaccines.
Ortiz Moyano R, Raya Tonetti F, Elean M, Imamura Y, Fukuyama K, Suda Y, Melnikov V, Suvorov A, Vizoso-Pinto MG, Kitazawa H, Villena J. Ortiz Moyano R, et al. Vaccines (Basel). 2024 Apr 12;12(4):412. doi: 10.3390/vaccines12040412. Vaccines (Basel). 2024. PMID: 38675794 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials